共 32 条
[21]
Levine A.J., Momand J., Finlay C.A., The p53 tumour suppressor gene, Nature, 351, pp. 453-456, (1991)
[22]
Milner J., Medcalf E.A., Cook A.C., Tumor suppressor p53: Analysis of wild-type and mutant p53 complexes, Mol Cell Biol, 11, pp. 12-19, (1991)
[23]
Varley J.M., Brammar W.J., Lane D.P., Swallow E.S., Dolan C., Walker R.A., Loss of chromosome l7p13 sequences and mutation of p53 in human breast carcinomas, Oncogene, 6, pp. 413-421, (1991)
[24]
Spandidos D.A., Karaiossifidi H., Malliri A., Linardopoulos S., Vassilaros S., Tsikkinis A., Field J.K., Expression of Ras Rbl and p53 proteins in human breast cancer, Anticancer Res, 12, pp. 81-90, (1992)
[25]
Cattoretti G., Rilke F., Andreola S., D'Amato L., Delia D., p53 expression in breast cancer, Int J Cancer, 41, pp. 178-183, (1988)
[26]
Cattoretti G., Andreola S., Clemente C., D'Amato L., Rilke F., Vimentin and p53 expression on epidermal growth factor receptor-positive oestrogen-negative breast carcinomas, Br J Cancer, 57, pp. 353-357, (1988)
[27]
Thompson A.M., Steel C.M., Chetty U., Hawkins R.A., Miller W.R., Carter D.C., Forrest A.P.M., Evans H.J., p53 gene mRNA expression and chromosome 17p allele loss in breast cancer, Br J Cancer, 61, pp. 74-78, (1990)
[28]
Koutselini H., Malliri A., Field J.K., Spandidos D.A., p53 expression in cytological specimens from benign and malignant breast lesions, Anticancer Res, 11, pp. 1415-1420, (1991)
[29]
Noguchi M., Kitagawa H., Kinoshita K., Miyazaki I., Saito Y., Mizukami Y., Prognostic significance of p53 and c- erbB- 2 expression in operable breast cancer, Int J Oncol, 2, pp. 587-591, (1993)
[30]
McGuire W.L., Tandon A.K., Allred D.C., Chamness G.C., Clark G.M., How to use prognostic factors in axillary node-negative breast cancer patients, J Natl Cancer Inst, 82, pp. 1006-1015, (1990)